OptiLIGHT IPL Therapy: Physician FAQs

What is OptiLIGHT IPL Therapy?
OptiLIGHT is a light-based treatment that uses intense, broad-spectrum light to target signs of dry eye disease, specifically those related to Meibomian Gland Dysfunction (MGD). MGD is the leading cause of dry eye disease, responsible for around 86% of cases.

How does OptiLIGHT address dry eye disease?
The treatment reduces inflammation, a key underlying factor in MGD. Lumenis’ patented OPT™ (Optimal Pulse Technology) allows precise and controlled light therapy, reaching delicate contours safely and effectively, and breaking the cycle of inflammation associated with dry eye.

Who is OptiLIGHT suitable for?
OptiLIGHT is intended for patients aged 22 and older and can be used alongside other treatments like Meibomian gland expression, artificial tears, and warm compresses for comprehensive dry eye management.

How long does each treatment take?
Each session takes about 15 minutes, allowing easy integration into practice workflows.

How many treatments are needed for optimal results?
Patients typically experience results after 4 comfortable sessions with OptiLIGHT IPL.

What should patients expect after treatment?
Some patients may experience mild redness immediately following the procedure, which usually resolves within a few hours. Patients can typically resume daily activities per their doctor’s guidance.

What is the wavelength range for OptiLIGHT IPL?
The IPL technology used in OptiLIGHT operates within a wavelength range of 400 to 1200 nm. To target the MGD-specific range, a 590 nm cut-off filter is applied, limiting the active wavelength to between 590 and 1200 nm.

Is OptiLIGHT FDA approved?
Yes, Lumenis’ OptiLIGHT is the first and only IPL treatment FDA-approved specifically for managing dry eye disease due to Meibomian Gland Dysfunction (MGD).

Why Refer Your Patients to Looking Glass Optical?

At Looking Glass Optical, we prioritize the highest standard of patient care and strive to maintain strong partnerships with referring physicians. When you refer your patients to us for OptiLIGHT IPL therapy, you can be confident that they will receive comprehensive, top-tier treatment that aligns with your own standards of care.

Our practice is equipped with advanced technology, including the FDA-approved OptiLIGHT IPL therapy, designed specifically for the effective management of dry eye disease. Each patient undergoes a personalized treatment plan tailored to their unique needs, ensuring targeted and effective care.

We emphasize thorough diagnostic assessments, transparent communication, and compassionate follow-up care, keeping you informed of your patient’s progress at every step. Our commitment to excellence extends beyond the treatment itself—we aim to educate and empower patients to maintain their eye health long after their visit.

Refer your patients to Looking Glass Optical, where they will experience state-of-the-art care and the personalized attention they deserve.